Pearson AD, Mueller S, Filbin MG, et al. Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. European journal of cancer (Oxford, England : 1990). 2025;217:115230. doi:10.1016/j.ejca.2025.115230
Abou-Karam R, Cheng F, Gady S, Fahed AC. The Role of Genetics in Advancing Cardiometabolic Drug Development. Current atherosclerosis reports. 2024. doi:10.1007/s11883-024-01195-6
Panella R, Petri A, Desai BN, et al. MicroRNA-22 Is a Key Regulator of Lipid and Metabolic Homeostasis. International journal of molecular sciences. 2023;24(16). doi:10.3390/ijms241612870
Schlam I, Moges R, Morganti S, Tolaney SM, Tarantino P. Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2. Critical reviews in oncology/hematology. 2023:104090. doi:10.1016/j.critrevonc.2023.104090
Holtzman SH, Cohen R, Levin JM, Maraganore J, Signatories to the Statement. Chinese scientists and US leadership in the life sciences. Nat Biotechnol. 2019;37(11):1261-1263. doi:10.1038/s41587-019-0285-x
Mahmoudi M, Pakpour S, Perry G. Drug-Abuse Nanotechnology: Opportunities and Challenges. ACS Chem Neurosci. 2018;9(10):2288-2298. doi:10.1021/acschemneuro.8b00127